Uptravi FDA Approved Drugs
UPTRAVI [SelexipagC26H32N4O4S]
RX
- 0.2mg (oral tablet)
0.4mg (oral tablet)
0.6mg (oral tablet)
0.8mg (oral tablet)
1.2mg (oral tablet)
1.4mg (oral tablet)
1.6mg (oral tablet)
1mg (oral tablet)
Actelion Pharms LtdDec 21, 2015
- Method of treating pulmonary arterial hypertension comprising administering a crystalline form of selexipag.
- Method of treating pulmonary arterial hypertension comprising administering a pharmaceutical composition comprising selexipag.
- Method of treating pulmonary arterial hypertension comprising administering selexipag in combination with the endothelin receptor antagonist macitentan.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.